11.
1. Franchini M, Lippi G. Acquired factor V inhibitors: a systematic
review. J Thromb Thrombolysis 31: 449-457, 2011.
2. Olson NJ, Robert D, Hedayat AA, Liu X, Ornstein DL. Fatal hemorrhage due to a spontaneous factor V inhibitor with lupus anticoagulant properties. Blood Coagul Fibrinolysis 28: 407-410, 2017.
3. Olson NJ, Ornstein DL. Factor V inhibitors: a diagnostic and
therapeutic challenge. Arch Pathol Lab Med 141: 1728-1731,
2017.
4. Ashizawa M, et al. Acquired factor V inhibitor associated with
life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency. Hematology 18: 300-304, 2013.
5. Franchini M, Lippi G, Favaloro EJ. Acquired inhibitors of coagulation factors: part II. Semin Thromb Hemost 38: 447-453, 2012.
6. Ogawa H, Souri M, Kanouchi K, et al. A high titer of acquired
factor V inhibitor in a hemodialysis patient who developed arterial
thrombosis. Int J Hematol 109: 214-220, 2019.
7. Shen L, Dahlback B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol
Chem 269: 18735-18738, 1994.
8. Nakata K, Ueda S, Matsunaga H, et al. High titer of acquired fac-
12.
13.
14.
15.
16.
tor V inhibitor presenting with a pseudo-deficiency of multiple coagulation factors. Intern Med 57: 393-397, 2018.
Potgieter JJ, Damgaard M, Hillarp A. One-stage vs. chromogenic
assays in haemophilia A. Eur J Haematol 94 (Suppl 77): 38-44,
2015.
Mathijssen NC, Masereeuw R, Holme PA, et al. Increased volume
of distribution for recombinant activated factor VII and longer
plasma-derived factor VII half-life may explain their long lasting
prophylactic effect. Thromb Res 132: 256-262, 2013.
Huang JN, Koerper MA. Factor V deficiency: a concise review.
Haemophilia 14: 1164-1169, 2008.
Ang AL, Kuperan P, Ng CH, Ng HJ. Acquired factor V inhibitor.
A problem-based systematic review. Thromb Haemost 101: 852859, 2009.
de Raucourt E, Barbier C, Sinda P, Dib M, Peltier JY, Ternisien C.
High-dose intravenous immunoglobulin treatment in two patients
with acquired factor V inhibitors. Am J Hematol 74: 187-190,
2003.
Hirai D, Yamashita Y, Masunaga N, et al. Acquired factor V inhibitor. Intern Med 55: 3039-3042, 2016.
Kadohira Y, Yamada S, Hayashi T, Morishita E, Asakura H,
Ichinose A. A discrepancy between prothrombin time and normo
test (hepaplastin test) results is useful for diagnosis of acquired
factor V inhibitors. Int J Hematol 108: 145-150, 2018.
Yamada S, Asakura H. Acquired factor V inhibitor. Rinsho Ketsueki 61: 791-798, 2020 (in Japanese).
The Internal Medicine is an Open Access journal distributed under the Creative
Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To
view the details of this license, please visit (https://creativecommons.org/licenses/
by-nc-nd/4.0/).
Ⓒ 2021 The Japanese Society of Internal Medicine
Intern Med 60: 2663-2666, 2021
2666
...
論文の公開元へ
